GlassScriptPhysician profile
Ailec E Estrada
NPI 1508196684
$2,318.30
in general payments reported to CMS, 2019-2025
28 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.44 · 2022: $109 · 2023: $220 · 2024: $759 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $423.91 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $305.12 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Tandem Diabetes Care, INC. | $187.06 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $162.39 | 2024-2025 | Korlym |
| Abbott Laboratories | $122.46 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $117.55 | 2023-2025 | |
| Dexcom, INC. | $113.14 | 2022-2025 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $106.99 | 2025 | Twiist |
| Beta Bionics, INC. | $96.05 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.37 | 2024-2025 | Jardiance, Synjardy |
| Xeris Pharmaceuticals, INC. | $82.64 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Insulet Corporation | $62.80 | 2021-2024 | Omnipod |
| Abbvie INC. | $44.75 | 2022-2024 | |
| Glaxosmithkline, LLC. | $42.57 | 2025 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $42.48 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $42.38 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $35.49 | 2023-2024 | |
| Madrigal Pharmaceuticals | $27.87 | 2025 | Rezdiffra |
| Averitas Pharma INC. | $26.41 | 2023 | Qutenza |
| Ibsa Pharma INC. | $24.86 | 2025 | Tirosint, Flector, Licart |
| Exact Sciences Corporation | $22.90 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $22.86 | 2025 | Thinprep 2000 Processor, Aptima |
| Osprey Medical INC | $21.76 | 2021 | |
| Mannkind Corporation | $20.43 | 2024 | |
| Medtronic, INC. | $18.73 | 2024 | Mycarelink |
| Abiomed | $18.68 | 2025 | |
| Rgh Enterprises LLC | $17.32 | 2024 | |
| Acella Pharmaceuticals, LLC | $14.33 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ailec Estrada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.